Well we can dream and aim high right?! I do agree with TS555 though that regardless of who wrote it there is a TON of great DD and facts which new investors should certainly take the time to read (and even follow up on, so the’ll See for themselves that it’s factual). I also agree that RXMD will likely be the OTC darling of 2018!!!